Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objectives of this trial were to determine the safety, tolerability, and MTD of
BIBF 1120 when added to standard therapy with carboplatin and paclitaxel